Organon Q3 2024 Adj EPS $0.87 Misses $0.90 Estimate, Sales $1.58B Beat $1.56B Estimate
Portfolio Pulse from Benzinga Newsdesk
Organon reported Q3 2024 earnings per share of $0.87, missing the consensus estimate of $0.90. However, the company exceeded sales expectations with $1.58 billion, surpassing the $1.56 billion estimate and marking a 4.15% increase from the previous year.
October 31, 2024 | 11:31 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Organon's Q3 2024 earnings per share of $0.87 missed the consensus estimate of $0.90, but sales of $1.58 billion beat expectations and increased by 4.15% year-over-year.
The mixed earnings report, with EPS missing but sales beating expectations, suggests a neutral short-term impact on Organon's stock price. The sales beat and year-over-year growth are positive, but the EPS miss could offset these gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100